You are here

SARC033 - SPORE06

Active
Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That Is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery
Type of Sarcoma: 
Epithelioid Hemangioendothelioma
Drug: 
Trametnib
Accrual Status: 
Recruiting
Overall Study Principal Investigator: 
Scott Schuetze, MD, PhD
Division of Hematology/Oncology
University of Michigan
 

For more information about this trial and open sites: